AMLX
Price
$13.83
Change
-$0.66 (-4.55%)
Updated
Feb 4, 02:21 PM (EDT)
Capitalization
1.59B
56 days until earnings call
Intraday BUY SELL Signals
GELS
Price
$0.86
Change
+$0.01 (+1.18%)
Updated
Feb 4, 02:37 PM (EDT)
Capitalization
9.17M
Intraday BUY SELL Signals
Interact to see
Advertisement

AMLX vs GELS

Header iconAMLX vs GELS Comparison
Open Charts AMLX vs GELSBanner chart's image
Amylyx Pharmaceuticals
Price$13.83
Change-$0.66 (-4.55%)
Volume$300
Capitalization1.59B
Gelteq
Price$0.86
Change+$0.01 (+1.18%)
Volume$200
Capitalization9.17M
AMLX vs GELS Comparison Chart in %
AMLX
Daily Signal:
Gain/Loss:
GELS
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
AMLX vs. GELS commentary
Feb 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMLX is a Hold and GELS is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 05, 2026
Stock price -- (AMLX: $14.49 vs. GELS: $0.85)
Brand notoriety: AMLX and GELS are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: AMLX: 83% vs. GELS: 3%
Market capitalization -- AMLX: $1.59B vs. GELS: $9.17M
AMLX [@Pharmaceuticals: Generic] is valued at $1.59B. GELS’s [@Pharmaceuticals: Generic] market capitalization is $9.17M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $64.79B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.75B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMLX’s FA Score shows that 0 FA rating(s) are green whileGELS’s FA Score has 0 green FA rating(s).

  • AMLX’s FA Score: 0 green, 5 red.
  • GELS’s FA Score: 0 green, 5 red.
According to our system of comparison, both AMLX and GELS are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMLX’s TA Score shows that 4 TA indicator(s) are bullish while GELS’s TA Score has 4 bullish TA indicator(s).

  • AMLX’s TA Score: 4 bullish, 6 bearish.
  • GELS’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, both AMLX and GELS are a bad buy in the short-term.

Price Growth

AMLX (@Pharmaceuticals: Generic) experienced а -6.33% price change this week, while GELS (@Pharmaceuticals: Generic) price change was -17.66% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -1.83%. For the same industry, the average monthly price growth was -2.35%, and the average quarterly price growth was +12.98%.

Reported Earning Dates

AMLX is expected to report earnings on Apr 01, 2026.

Industries' Descriptions

@Pharmaceuticals: Generic (-1.83% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AMLX($1.59B) has a higher market cap than GELS($9.17M). AMLX YTD gains are higher at: 19.950 vs. GELS (6.012). GELS has higher annual earnings (EBITDA): -1.6M vs. AMLX (-156.76M). GELS has higher revenues than AMLX: GELS (0) vs AMLX (-665K).
AMLXGELSAMLX / GELS
Capitalization1.59B9.17M17,346%
EBITDA-156.76M-1.6M9,816%
Gain YTD19.9506.012332%
P/E Ratio2.69N/A-
Revenue-665K0-
Total Cash344MN/A-
Total Debt5.94MN/A-
TECHNICAL ANALYSIS
Technical Analysis
AMLXGELS
RSI
ODDS (%)
Bearish Trend 2 days ago
71%
Bearish Trend 2 days ago
75%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
78%
Advances
ODDS (%)
Bullish Trend 15 days ago
78%
Bullish Trend 14 days ago
74%
Declines
ODDS (%)
Bearish Trend 10 days ago
82%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
AMLX
Daily Signal:
Gain/Loss:
GELS
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PDEZX22.150.34
+1.56%
PGIM Jennison Emerging Markets Eq Opps Z
SOIUX21.240.29
+1.38%
Spirit of America Utilts Inst
ISMSX10.330.04
+0.39%
VY® American Century Sm-Mid Cp Val S2
PAADX17.32-0.06
-0.35%
Putnam Dynamic Asset Allocation Bal R5
PRSCX60.80-0.45
-0.73%
T. Rowe Price Science & Tech

AMLX and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMLX has been closely correlated with XOMAO. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if AMLX jumps, then XOMAO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMLX
1D Price
Change %
AMLX100%
-1.23%
XOMAO - AMLX
68%
Closely correlated
-0.39%
XOMAP - AMLX
51%
Loosely correlated
+1.00%
OCUL - AMLX
46%
Loosely correlated
-6.99%
LRMR - AMLX
45%
Loosely correlated
-1.71%
RGNX - AMLX
43%
Loosely correlated
+0.74%
More

GELS and

Correlation & Price change

A.I.dvisor tells us that GELS and HCM have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GELS and HCM's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GELS
1D Price
Change %
GELS100%
-10.05%
HCM - GELS
30%
Poorly correlated
-1.17%
BFRI - GELS
25%
Poorly correlated
-4.13%
AMLX - GELS
24%
Poorly correlated
-1.23%
DERM - GELS
22%
Poorly correlated
-0.47%
EVO - GELS
22%
Poorly correlated
+10.82%
More